Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.50, $0.13 worse than the analyst estimate of $0.63. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE